Ben Comer

Most Recent Articles by Ben Comer

Forest Labs to acquire Clinical Data, add reps for launch

Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a conference call.

Savient focusing on reimbursement

Savient Pharmaceuticals launched Krystexxa, an orphan drug for chronic gout, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers.

Ex-GSK marketer unveils migraine consumer site

Health Union, an online health information and social media company, announced the launch of its first website --Migraine.com--intended to foster "interactions about health conditions between and among patients, caregivers, professionals and providers."

Roche maintained DTC spending on Boniva, while competitors cut back

Roche maintained DTC spending on Boniva, while competitors cut back

Sally Field's winsome smile may have helped to curb declining sales of Roche's Boniva in 2010, but it didn't carry the drug past Warner Chilcott's Actonel, despite a substantially higher DTC spend.

Savient focuses on reimbursement for Krystexxa launch

Savient focuses on reimbursement for Krystexxa launch

Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.

More Articles by Ben Comer

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.